Oscar Health (NYSE:OSCR) Insider Sells $273,701.50 in Stock

Oscar Health, Inc. (NYSE:OSCR) insider Janet Liang sold 12,475 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $273,701.50. Following the completion of the transaction, the insider directly owned 259,057 shares of the company’s stock, valued at $5,683,710.58. This trade represents a 4.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Performance

Shares of OSCR stock opened at $24.59 on Friday. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $25.58. The firm has a market capitalization of $7.41 billion, a price-to-earnings ratio of -41.68, a price-to-earnings-growth ratio of 1.71 and a beta of 2.37. The business has a 50 day simple moving average of $18.39 and a 200 day simple moving average of $16.06. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. During the same period in the prior year, the company posted $0.92 EPS. The business’s revenue for the quarter was up 52.6% compared to the same quarter last year. On average, equities research analysts anticipate that Oscar Health, Inc. will post 0.47 EPS for the current year.

Trending Headlines about Oscar Health

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Wells Fargo upgraded Oscar Health from “strong sell” to “hold”, easing bearish sentiment even though its $20 target remains below the current share price. Zacks.com
• Positive Sentiment: Oscar Health’s recent earnings showed a major EPS beat, which supports the stock’s fundamental story despite revenue coming in below estimates.
• Neutral Sentiment: A company co-founder shifting into an advisory leadership role looks like an internal reorganization rather than a disruptive change. Oscar Health Co-Founder Shifts to Advisory Leadership Role
• Neutral Sentiment: Multiple insiders, including CFO Richard Scott Blackley and CAO Victoria Baltrus, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.
• Negative Sentiment: Director Mario Schlosser sold 34,120 shares, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.

Institutional Investors Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently bought and sold shares of OSCR. Jones Financial Companies Lllp raised its position in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares in the last quarter. Strs Ohio bought a new stake in Oscar Health in the first quarter worth about $30,000. Fifth Third Bancorp raised its position in Oscar Health by 148.7% in the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after acquiring an additional 1,413 shares in the last quarter. Quarry LP raised its position in Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after acquiring an additional 1,469 shares in the last quarter. Finally, Tsfg LLC bought a new stake in Oscar Health in the third quarter worth about $38,000. 75.70% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a report on Tuesday, April 21st. Barclays increased their price objective on Oscar Health from $21.00 to $30.00 and gave the stock an “equal weight” rating in a report on Tuesday, May 26th. Wall Street Zen lowered Oscar Health from a “strong-buy” rating to a “buy” rating in a report on Saturday. Wells Fargo & Company set a $20.00 price target on Oscar Health and gave the company an “equal weight” rating in a research note on Thursday. Finally, UBS Group increased their price target on Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Oscar Health presently has an average rating of “Hold” and an average price target of $20.22.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.